Researchers Halt Trials of Promising Sickle Cell Treatment
Advertisement Continue reading the main story Supported by Continue reading the main story Researchers Halt Trials of Promising Sickle Cell Treatment Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible. Researchers working in the cellular and molecular therapeutics branch at the National Heart,… Read More »